Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial

被引:34
作者
Adams, KF
Lampe, PD
Newton, KM
Ylvisaker, JT
Feld, A
Myerson, D
Emerson, SS
White, E
Potter, JD
Lampe, JW [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA USA
关键词
soy isoflavone; genestein; randomized controlled trial; colon; epithelial cell proliferation; Ki-67; antibody;
D O I
10.1093/ajcn/82.3.620
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Soy isoflavones have numerous biological properties that suggest that they may protect against colorectal cancer. Colorectal epithelial cell proliferation has been used extensively as an intermediate endpoint biomarker for colorectal neoplasia. Objective: We tested the hypothesis that supplementation with soy protein containing isoflavones decreases colorectal epithelial cell proliferation. Design: A 12-mo randomized intervention was conducted in men and women aged 50-80 y with recently diagnosed adenomatous polyps. One hundred fifty participants were enrolled and randomly assigned to an active treatment group (58 g protein powder/d containing 83 mg isoflavones/d; +ISO) or a control group (ethanol-extracted soy-protein powder containing 3 mg isoflavones; -ISO). Biopsy specimens from the cecum, sigmoid colon, and rectum were collected at baseline and at the 12-mo follow-up. Ki-67 antibody immunohistostaining was used to detect cell proliferation. One hundred twenty-five participants completed the study, and proliferation was measured in the first 91 who completed the study. Results: In the sigmoid colon, cell proliferation increased by 0.9 (95% CI: 0.09,1.9) labeled nuclei per crypt more (11%) in the +ISO group than in the -ISO group over the 12-mo intervention, which was opposite the direction predicted. The number of labeled nuclei per 100 mu m crypt height also increased more in the +ISO than in the ASO group. In the cecum and sigmoid colon, but not in the rectum, the proliferation count increased as the serum genistein concentration increased. Proliferation distribution and crypt height were not changed by treatment at any site. Conclusions: Supplementation with soy protein containing isoflavones does not reduce colorectal epithelial cell proliferation or the average height of proliferating cells in the cecum, sigmoid colon, and rectum and increases cell proliferation measures in the sigmoid colon.
引用
收藏
页码:620 / 626
页数:7
相关论文
共 40 条
[1]  
Adams KF, 2003, J NUTR, V133, P1316
[2]   Phyto-oestrogens and cancer [J].
Adlercreutz, H .
LANCET ONCOLOGY, 2002, 3 (06) :364-373
[3]   PHYTOESTROGENS - EPIDEMIOLOGY AND A POSSIBLE ROLE IN CANCER PROTECTION [J].
ADLERCREUTZ, H .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 :103-112
[4]  
Baron J A, 2001, IARC Sci Publ, V154, P113
[5]   CALCIUM SUPPLEMENTATION AND RECTAL MUCOSAL PROLIFERATION - A RANDOMIZED CONTROLLED TRIAL [J].
BARON, JA ;
TOSTESON, TD ;
WARGOVICH, MJ ;
SANDIER, R ;
MANDEL, J ;
BOND, J ;
HAILE, R ;
SUMMERS, R ;
VANSTOLK, R ;
ROTHSTEIN, R ;
WEISS, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (17) :1303-1307
[6]   A randomized trial of aspirin to prevent colorectal adenomas [J].
Baron, JA ;
Cole, BF ;
Sandler, RS ;
Haile, RW ;
Ahnen, D ;
Bresalier, R ;
McKeown-Eyssen, G ;
Summers, RW ;
Rothstein, R ;
Burke, CA ;
Snover, DC ;
Church, TR ;
Allen, JI ;
Beach, M ;
Beck, GJ ;
Bond, JH ;
Byers, T ;
Greenberg, ER ;
Mandel, JS ;
Marcon, N ;
Mott, LA ;
Pearson, L ;
Saibil, F ;
van Stolk, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899
[7]  
Bennink MR, 2001, ADV EXP MED BIOL, V492, P11
[8]   Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro [J].
Booth, C ;
Hargreaves, DF ;
Hadfield, JA ;
McGown, AT ;
Potten, CS .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1550-1557
[9]  
Bostick RM, 1997, CANCER EPIDEM BIOMAR, V6, P931
[10]   CALCIUM AND COLORECTAL EPITHELIAL-CELL PROLIFERATION IN SPORADIC ADENOMA PATIENTS - A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED CLINICAL-TRIAL [J].
BOSTICK, RM ;
FOSDICK, L ;
WOOD, JR ;
GRAMBSCH, P ;
GRANDITS, GA ;
LILLEMOE, TJ ;
LOUIS, TA ;
POTTER, JD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (17) :1307-1315